Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C

Abstract

Elderly patients with chronic HCV can be treated successfully. However, they are more at risk to develop cytopenias while on treatment. In such patients, the close monitoring of blood counts is necessary. Larger studies are needed to confirm these findings and to determine whether SVR differs in this population.